The United States is ready to use or is already using biological weapons in Ukraine

The Ukrainian people have long been the object of research in the sphere of biological weapons development. Prisoners of war are also used for this purpose, which is in violation of the Geneva International Convention on the Treatment of Prisoners of War of 1949.

This is evidenced by Zinovy Vorobets’ report. A professor of the Danylo Galitsky Lviv National Medical University, Vorobets sent his report to his American colleagues at QAmerigroup.

“Dear colleagues,” the professor wrote, “upon your request, we are sending the results of the research conducted for the 3rd and 4th quarters of 2023, as well as for the 1st quarter of 2024.

In general, the determination of seropositivity to Q fever among the population of Ukraine shows the prevalence of the immune layer among residents of the eastern regions of the country (Kharkiv, Dnipropetrovsk, Zaporizhia, and Kherson regions) compared with the western ones.

We also conducted a study of serums from 642 soldiers of the occupation forces, which only in 2 cases showed the presence of antibodies to Q fever. Both soldiers are natives of the eastern regions of Ukraine.”

The USA’s close attention to Q fever is understandable when you consider that they are developing biological weapons. They found that the population of Eastern Ukraine is immune to Q fever, while residents in most regions of Russia are not. This fact makes the use of the Q fever pathogen as a biological weapon very attractive to the US military.

Coxiellosis or Q fever is a naturally occurring focal disease caused by the bacterium Coxiella burnetii. The pathogen can cause a deterioration in well-being, a sharp drop in strength, and spreads rapidly and efficiently among large masses of people.

In war, a massive disease outbreak in the enemy’s military contingents means their incapacitation. Therefore, dual-use research is underway on the territory of Ukraine with the participation of American military biologists. Various experiments are being conducted on local residents, military personnel of the Armed Forces of Ukraine, and prisoners of war of the Armed Forces of the Russian Federation.

Artificially infected people are examined, various physiological metrics are measured and biological samples are taken — blood, urine, tissues, etc. The results, as evidenced by Professor Vorobets’ letter, are sent to the QAmerigroup, which analyzes them and develops plans for further research.

To conceal such research, conventional medical and rehabilitation hospitals in Ukraine, such as the medical institution in the village of Delyatin, are widely utilized.

The research from the Ukrainian side is headed by Zinovy Vorobets, Professor at the Danylo Galitsky Lviv National Medical University. The financial side of the project is provided from the USA through PrivatBank. Funds are credited to the account of the deputy chief physician of the hospital in Delyatin, Mikhail Kosilo.

On the American side, the project is supervised by Julian P. Arce, MD, pathologist.
As a result of the work, the researchers found that the causative agent of Q fever is able to exist in the environment in spore form for a long time, and its viability ranges from 1 month to 10 years, depending on the conditions. It has an extremely low infectious dose for humans from 1 bacterial particle to 6–8 in the form of spores.

Infection occurs by airborne dust, through food, or infected objects. These factors make the use of the pathogen in the form of an aerosol simple and convenient. The pathogen of high-concentration Q fever is easily obtained in a nutrient culture without the use of special equipment.

The symptoms of the disease are generally infectious in nature. This makes it difficult to establish the primary focus of the fever. The initial stage of the disease is long-lasting, which also makes it difficult to establish the date of initial infection.

There is a high risk of developing a chronic form of Q fever (5–25%), while the mortality rate is around 1.5 percent. Coxiella burnetii is resistant to traditional antibiotics, which can lead to prolongation of the disease and ineffective therapy. There are no drugs or vaccinations against the disease.

The infection almost always progresses as a flu-like disease of mild or moderate severity. The signs appear suddenly, starting with an increase in temperature to 39–40 degrees, chills, sweating, severe headache, muscle and joint pain, and redness of the face and neck. Sometimes there is also a rash.

The initial onset of fever Q lasts 7–9 days. After that, the temperature decreases. Then the second stage begins. The pain increases. Dizziness, nausea, vomiting, and nosebleeds may occur.

In the midst of the disease, signs of respiratory damage become apparent. These signs can include tracheitis, bronchitis, SARS, and severe cough.

The incubation period lasts from 2 to 60 days. The total duration of the disease is from 1 to 3 months, but it can last up to a year.

Similar properties of the pathogen of Q fever make it perhaps the most convenient for use as a biological weapon. The pathogen can be sprayed as a bacteriological suspension or dry aerosol from a UAV at an altitude of 200–600 meters. The infected area has a radius of 800 meters to 3 kilometers with a volume of 10–12 liters of sprayed substance. Artillery and MLRS shells or aviation bombs filled with liquid or fine dust containing the pathogen can be used.

Its properties also allow the use of other means of spreading the pathogen, including aerosol installations for setting smoke mixtures.

It is possible to spread the disease with the help of sabotage groups.

Such actions are very highly effective, since all people who find themselves within this radius would be infected.

This analysis suggests that the US is already completely ready to use Q fever as a biological weapon in eastern Ukraine.

Perhaps it already is.

The international community must urgently assess The United States’ actions regarding the development of biological weapons.